Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry Science

Anubha Agarwal1, Jasper Tromp2, Wael Almahmeed3

  • 1Washington University in St. Louis School of Medicine, MO (A.A.).

PubMed

Insights

Heart failure (HF) registries need better ways to track causes and risk factors. Improving these registries can help reduce the global burden of noncommunicable diseases.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Registries

Background:

  • Heart failure (HF) is a common endpoint for many diseases, but understanding and tracking its underlying causes (etiologies) is challenging.
  • Current HF registries exhibit overlap in how they define etiologies, comorbidities, and cases, leading to confusion.
  • Standardizing the description and study of HF etiologies is crucial for effective management and research.

Purpose of the Study:

  • To analyze the overlap in HF etiologies, comorbidities, and case definitions within global HF registries.
  • To propose strategies for enhancing the quality of evidence regarding HF etiologies and modifiable risk factors in registries.
  • To explore the potential of clinical HF registries for public health surveillance, implementation research, and clinical trials.

Main Methods:

  • Review and analysis of current practices in HF registries managed by the global HF roundtable.
  • Identification of commonalities and discrepancies in HF etiology and comorbidity definitions.
  • Exploration of registry data for public health applications and research.

Main Results:

  • Significant overlap and confusion exist in the current definitions and tracking of HF etiologies across registries.
  • Strategies are needed to improve data quality and standardization for better evidence generation.
  • Clinical HF registries offer untapped potential for broader public health initiatives.

Conclusions:

  • Standardizing HF etiology definitions and improving data quality in global registries are essential.
  • Enhanced HF registries can serve as powerful platforms for surveillance and research.
  • International collaboration and investment in HF registries can significantly reduce the global burden of noncommunicable diseases.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
173
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
400
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337